Literature DB >> 16458358

Nonheme iron(II) complexes of macrocyclic ligands in the generation of oxoiron(IV) complexes and the catalytic epoxidation of olefins.

Yumi Suh1, Mi Sook Seo, Kwan Mook Kim, Youn Sang Kim, Ho G Jang, Takehiko Tosha, Teizo Kitagawa, Jinheung Kim, Wonwoo Nam.   

Abstract

Mononuclear nonheme oxoiron(IV) complexes bearing 15-membered macrocyclic ligands were generated from the reactions of their corresponding iron(II) complexes and iodosylbenzene (PhIO) in CH(3)CN. The oxoiron(IV) species were characterized with various spectroscopic techniques such as UV-vis spectrophotometer, electron paramagnetic resonance, electrospray ionization mass spectrometer, and resonance Raman spectroscopy. The oxoiron(IV) complexes were inactive in olefin epoxidation. In contrast, when iron(II) or oxoiron(IV) complexes were combined with PhIO in the presence of olefins, high yields of epoxide products were obtained. These results indicate that in addition to the oxoiron(IV) species, there must be at least one more active oxidant (e.g., Fe(IV)-OIPh adduct or oxoiron(V) species) that effects the olefin epoxidation. We have also demonstrated that the ligand environment of iron catalysts is an important factor in controlling the catalytic activity as well as the product selectivity in the epoxidation of olefins by PhIO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458358     DOI: 10.1016/j.jinorgbio.2005.12.013

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  9 in total

Review 1.  Chemistry of polyvalent iodine.

Authors:  Viktor V Zhdankin; Peter J Stang
Journal:  Chem Rev       Date:  2008-12       Impact factor: 60.622

2.  An inverted and more oxidizing isomer of [Fe(IV)(O)(tmc)(NCCH3)]2+.

Authors:  Kallol Ray; Jason England; Adam T Fiedler; Marlène Martinho; Eckard Münck; Lawrence Que
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

3.  Kinetic analysis of the conversion of nonheme (alkylperoxo)iron(III) species to iron(IV) complexes.

Authors:  Michael P Jensen; Antoni Mairata I Payeras; Adam T Fiedler; Miquel Costas; József Kaizer; Audria Stubna; Eckard Münck; Lawrence Que
Journal:  Inorg Chem       Date:  2007-02-28       Impact factor: 5.165

4.  High-Valent Nonheme Iron Oxidants in Biology: Lessons from Synthetic FeIV=O Complexes.

Authors:  Lawrence Que
Journal:  Bull Jpn Soc Coord Chem       Date:  2013-11

5.  Electronic Structure and Reactivity of Dioxygen-Derived Aliphatic Thiolate-Ligated Fe-Peroxo and Fe(IV) Oxo Compounds.

Authors:  Maksym A Dedushko; Maria B Greiner; Alexandra N Downing; Michael Coggins; Julie A Kovacs
Journal:  J Am Chem Soc       Date:  2022-05-06       Impact factor: 16.383

6.  Influence of the nitrogen donors on nonheme iron models of superoxide reductase: high-spin Fe(III)-OOR complexes.

Authors:  Frances Namuswe; Takahiro Hayashi; Yunbo Jiang; Gary D Kasper; Amy A Narducci Sarjeant; Pierre Moënne-Loccoz; David P Goldberg
Journal:  J Am Chem Soc       Date:  2010-01-13       Impact factor: 15.419

7.  What factors influence the reactivity of C-H hydroxylation and C=C epoxidation by [Fe(IV)(L(ax))(1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane)(O)](n+).

Authors:  Wang Yi; Liu Yuan; Yang Kun; He Zhengwen; Tian Jing; Fei Xu; Guo Hong; Wang Yong
Journal:  J Biol Inorg Chem       Date:  2015-09-07       Impact factor: 3.358

8.  Reaction of an iron(IV) nitrido complex with cyclohexadienes: cycloaddition and hydrogen-atom abstraction.

Authors:  Wei-Tsung Lee; Ruth A Juarez; Jeremiah J Scepaniak; Salvador B Muñoz; Diane A Dickie; Haobin Wang; Jeremy M Smith
Journal:  Inorg Chem       Date:  2014-07-28       Impact factor: 5.165

9.  Chemoselectivity in the Oxidation of Cycloalkenes with a Non-Heme Iron(IV)-Oxo-Chloride Complex: Epoxidation vs. Hydroxylation Selectivity.

Authors:  Thibault Terencio; Erik Andris; Ilaria Gamba; Martin Srnec; Miquel Costas; Jana Roithová
Journal:  J Am Soc Mass Spectrom       Date:  2019-08-09       Impact factor: 3.109

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.